SCHEMBL2170552

SCHEMBL2170552

CCCC(=O)OOc1ccccc1C(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.43
PPARG P37231 2/20 0.43
RXRA P19793 1/20 0.43
RXRB P28702 1/20 0.43
RXRG P48443 1/20 0.43
F2R P25116 1/20 0.40
ATM Q13315 1/20 0.40
MRGPRX4 Q96LA9 1/20 0.40
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
LMNA P02545 1/20 0.39
KCNK3 O14649 1/20 0.39
KCNK9 Q9NPC2 1/20 0.39
MCL1 Q07820 1/20 0.38
MAOB P27338 1/20 0.37
NOTUM Q6P988 1/20 0.37
SSTR4 P31391 2/20 0.37
POLB P06746 1/20 0.37
MAPK1 P28482 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1997892 0.84 PPARG (0.48) ALDH1A1PPARGRXRARXRBRXRG
SCHEMBL1577430 0.79 PPARG (0.44) PPARGRXRARXRBRXRGATM
SCHEMBL27345094 0.78 AOC2 (0.43) RXRARXRBRXRGATMKMT2A
SCHEMBL10975745 0.76 MEN1 (0.39) ALDH1A1F2RKMT2AMEN1LMNA
SCHEMBL27602777 0.76 ALDH1A1 (0.48) ALDH1A1RXRARXRBKMT2AMEN1
SCHEMBL1998648 0.76 MEN1 (0.60) ALDH1A1PPARGRXRARXRBRXRG
SCHEMBL4214268 0.75 ALDH1A1 (0.51) ALDH1A1PPARGRXRARXRBRXRG
SCHEMBL4214258 0.75 ALDH1A1 (0.51) ALDH1A1PPARGRXRARXRBRXRG
SCHEMBL10930171 0.74 PPARG (0.43) PPARGRXRARXRBRXRGATM
SCHEMBL2002076 0.74 PPARG (0.50) PPARGRXRARXRBRXRGATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8252781-B2 1,2-diazetidin-3-one derivatives and drugs containing same KOWA COMPANY, LTD. (JP) 2012-08-28 US disclosed
EP-2348019-A1 1,2-DIAZETIDIN-3-ONE DERIVATIVE AND PHARMACEUTICAL AGENT COMPRISING SAME Kowa Company, Ltd. (JP) 2011-07-27 EP disclosed
US-20100144694-A1 1,2-DIAZETIDIN-3-ONE DERIVATIVES AND DRUGS CONTAINING SAME KOWA COMPANY, LTD. (JP) 2010-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100144694-A1 1,2-DIAZETIDIN-3-ONE DERIVATIVES AND DRUGS CONTAINING SAME HSD11B1, HSD11B2, HSD3B1 ALDH1A1 157/4885PPARG 332/4885RXRA 1599/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.